{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:57:45Z","timestamp":1789012665160,"version":"build-2803163510"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Cancer Institute (NCI) Cancer Center","award":["30 CA008748"],"award-info":[{"award-number":["30 CA008748"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,21]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There are limited data for letermovir as primary cytomegalovirus (CMV) prophylaxis in patients less than 18 years of age. We report 9 adolescent patients who received letermovir following hematopoietic cell transplantation. No patients developed clinically significant CMV while taking letermovir. Letermovir was well tolerated and efficacious in preventing CMV infections.<\/jats:p>","DOI":"10.1093\/jpids\/piac017","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T20:12:07Z","timestamp":1646683927000},"page":"337-340","source":"Crossref","is-referenced-by-count":26,"title":["Letermovir for Cytomegalovirus Prevention in Adolescent Patients Following Hematopoietic Cell Transplantation"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5975-1245","authenticated-orcid":false,"given":"Nicole","family":"P Daukshus","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Memorial Sloan Kettering Cancer Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Cirincione","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Maine Medical Center , Portland, Maine , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Siver","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hackensack University Medical Center , Hackensack, New Jersey , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Memorial Sloan Kettering Cancer Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binni","family":"Kunvarjee","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Memorial Sloan Kettering Cancer Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Memorial Sloan Kettering Cancer Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap Jan","family":"Boelens","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K","family":"Seo","sequence":"additional","affiliation":[{"name":"Infectious Disease Service, Memorial Sloan Kettering Cancer Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genovefa A","family":"Papanicolaou","sequence":"additional","affiliation":[{"name":"Infectious Disease Service, Memorial Sloan Kettering Cancer Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A","family":"Kernan","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"2023030708273325200_","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.2019000956","article-title":"How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation.","volume":"135","author":"Einsele","year":"2020","journal-title":"Blood"},{"key":"2023030708273325200_","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients.","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"2023030708273325200_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-017-0180-z","article-title":"Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation.","volume":"7","author":"Styczynski","year":"2018","journal-title":"Infect Dis Ther"},{"key":"2023030708273325200_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.01186","article-title":"Human cytomegalovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients.","volume":"10","author":"Stern","year":"2019","journal-title":"Front Microbiol"},{"key":"2023030708273325200_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20112666","article-title":"Cytomegalovirus infections after hematopoietic stem cell transplantation: current status and future immunotherapy.","volume":"20","author":"Cho","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023030708273325200_","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/bmt.2013.164","article-title":"Survey of CMV management in pediatric allogeneic HSCT programs, on behalf of the inborn errors, infectious diseases and pediatric diseases working parties of EBMT.","volume":"49","author":"Bontant","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"2023030708273325200_","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/bloodadvances.2018016493","article-title":"Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation.","volume":"2","author":"Chen","year":"2018","journal-title":"Blood Adv"},{"key":"2023030708273325200_","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1358\/dof.2013.38.5.1946425","article-title":"Letermovir treatment of human cytomegalovirus infection antiinfective agent.","volume":"38","author":"Verghese","year":"2013","journal-title":"Drugs Future"},{"key":"2023030708273325200_","volume-title":"PREVYMIS (letermovir) Tablets and PREVYMIS (letermovir) Injection.","author":"Databases USFDA."},{"key":"2023030708273325200_","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation.","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"key":"2023030708273325200_","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1093\/jac\/dkz218","article-title":"Letermovir in paediatric HSCT recipients.","volume":"74","author":"Strenger","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2023030708273325200_","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1016\/j.bbmt.2019.12.382","article-title":"Timing of induction treatment for reactivation of cytomegalovirus impacts overall survival in pediatric allogeneic hematopoietic cell transplant.","volume":"26","author":"Camacho-Bydume","year":"2020","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/11\/7\/337\/49430222\/piac017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/11\/7\/337\/49430222\/piac017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T21:58:49Z","timestamp":1726783129000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/11\/7\/337\/6574501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":12,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4,26]]},"published-print":{"date-parts":[[2022,7,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piac017","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,4,26]]}}}